The complement system in the acute phase of myocardial infarction
Related Experiment Videos
M Yasuda1, T Kawarabayashi, K Akioka
1First Department of Internal Medicine, Osaka City University Medical School, Japan.
Insights
Complement activation, indicated by elevated C3a levels, occurs in acute myocardial infarction patients. This suggests a role for the complement system in heart damage following a heart attack.
Area of Science:
- Immunology
- Cardiology
- Biochemistry
Background:
- The role of complement activation in acute myocardial infarction (AMI) is debated, with limited evidence of complement system changes in patients.
- Previous research suggests a potential link, but definitive proof of complement system involvement in AMI pathogenesis is lacking.
Purpose of the Study:
- To investigate changes in the complement system in patients with acute myocardial infarction.
- To assess the levels of specific complement components and overall complement activity post-myocardial infarction.
Main Methods:
- Serial measurements of plasma C3a, C3, C4, and total hemolytic complement titer (CH50) were performed.
- 12 patients with acute myocardial infarction were monitored for up to 10 days post-attack.
- Levels were compared to control values.
Main Results:
- Plasma C3a levels were significantly elevated throughout the 10-day observation period following AMI.
- Levels of C3, C4, and CH50 showed significant increases on days 8, 9, and 10 post-infarction compared to controls.
- These findings demonstrate clear evidence of complement activation in AMI patients.
Conclusions:
- Complement activation is demonstrably present in patients experiencing acute myocardial infarction.
- The study suggests a pathogenetic role for complement activation in the myocardial damage that occurs after infarction.
- These results highlight the complement system as a potential therapeutic target in managing AMI.
Abstract:
Although some studies suggest that complement activation is involved in the development of acute myocardial infarction, there has been little convincing evidence of a change in the complement system in patients suffering from myocardial infarction. In this study circulating levels of C3a, C3, C4 and the total hemolytic complement titer (CH50) were serially measured in 12 patients with acute myocardial infarction up to 10 days after an attack. The plasma C3a level was greatly elevated throughout the post-attack observation period. The C3, C4 and CH50 levels were significantly increased above those controls on days 8, 9 and 10 after infarction. These findings indicate that there is complement activation in patients with acute myocardial infarction, and suggest a pathogenetic role for complement activation in the development of myocardial damage after infarction.